$INFU
InfuSystem Holdings, Inc

2017 Q2 Form 10-Q Financial Statement

#000119312517252772 Filed on August 09, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2
Revenue $16.94M $18.12M
YoY Change -6.52% 6.98%
Cost Of Revenue $4.624M $4.789M
YoY Change -3.45% 0.61%
Gross Profit $10.34M $11.14M
YoY Change -7.2% -8.51%
Gross Profit Margin 61.04% 61.49%
Selling, General & Admin $8.720M $8.716M
YoY Change 0.05% -10.33%
% of Gross Profit 84.32% 78.22%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.490M $1.120M
YoY Change 33.04% 38.27%
% of Gross Profit 14.41% 10.05%
Operating Expenses $11.43M $10.71M
YoY Change 6.8% 1.66%
Operating Profit -$1.092M $438.0K
YoY Change -349.32% -73.45%
Interest Expense $333.0K $327.0K
YoY Change 1.83% -183.85%
% of Operating Profit 74.66%
Other Income/Expense, Net -$399.0K -$320.0K
YoY Change 24.69%
Pretax Income -$1.491M $118.0K
YoY Change -1363.56% -83.14%
Income Tax -$385.0K -$35.00K
% Of Pretax Income -29.66%
Net Earnings -$1.106M $153.0K
YoY Change -822.88% -76.09%
Net Earnings / Revenue -6.53% 0.84%
Basic Earnings Per Share -$0.05 $0.01
Diluted Earnings Per Share -$0.05 $0.01
COMMON SHARES
Basic Shares Outstanding 22.74M 22.62M shares
Diluted Shares Outstanding 22.74M 23.11M shares

Balance Sheet

Concept 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $100.0K $800.0K
YoY Change -87.5% 0.0%
Cash & Equivalents $76.00K $805.0K
Short-Term Investments
Other Short-Term Assets $1.314M $1.207M
YoY Change 8.86% 15.61%
Inventory $1.962M $2.096M
Prepaid Expenses
Receivables $11.55M $16.95M
Other Receivables $0.00 $0.00
Total Short-Term Assets $14.90M $23.80M
YoY Change -37.41% 30.15%
LONG-TERM ASSETS
Property, Plant & Equipment $1.815M $2.236M
YoY Change -18.83% -6.44%
Goodwill
YoY Change
Intangibles $28.29M $31.86M
YoY Change -11.18% 19.83%
Long-Term Investments
YoY Change
Other Assets $61.00K $222.0K
YoY Change -72.52% -0.89%
Total Long-Term Assets $73.81M $76.46M
YoY Change -3.47% 4.05%
TOTAL ASSETS
Total Short-Term Assets $14.90M $23.80M
Total Long-Term Assets $73.81M $76.46M
Total Assets $88.71M $100.3M
YoY Change -11.53% 9.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.247M $5.346M
YoY Change -1.85% -15.22%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $2.660M $5.939M
YoY Change -55.21% -11.94%
Total Short-Term Liabilities $10.99M $13.85M
YoY Change -20.59% -14.74%
LONG-TERM LIABILITIES
Long-Term Debt $28.72M $33.48M
YoY Change -14.23% 19.44%
Other Long-Term Liabilities $100.0K
YoY Change
Total Long-Term Liabilities $29.02M $33.48M
YoY Change -13.33% 19.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.99M $13.85M
Total Long-Term Liabilities $29.02M $33.48M
Total Liabilities $40.01M $47.33M
YoY Change -15.46% 6.9%
SHAREHOLDERS EQUITY
Retained Earnings -$43.51M -$38.74M
YoY Change 12.3% -10.6%
Common Stock $2.000K $2.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $48.70M $52.94M
YoY Change
Total Liabilities & Shareholders Equity $88.71M $100.3M
YoY Change -11.53% 9.25%

Cashflow Statement

Concept 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income -$1.106M $153.0K
YoY Change -822.88% -76.09%
Depreciation, Depletion And Amortization $1.490M $1.120M
YoY Change 33.04% 38.27%
Cash From Operating Activities $2.670M $1.530M
YoY Change 74.51% -70.46%
INVESTING ACTIVITIES
Capital Expenditures -$870.0K -$3.920M
YoY Change -77.81% -32.41%
Acquisitions
YoY Change
Other Investing Activities $1.090M $950.0K
YoY Change 14.74% -131.35%
Cash From Investing Activities $220.0K -$2.970M
YoY Change -107.41% -66.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -3.010M 1.680M
YoY Change -279.17% 37.7%
NET CHANGE
Cash From Operating Activities 2.670M 1.530M
Cash From Investing Activities 220.0K -2.970M
Cash From Financing Activities -3.010M 1.680M
Net Change In Cash -120.0K 240.0K
YoY Change -150.0% -109.88%
FREE CASH FLOW
Cash From Operating Activities $2.670M $1.530M
Capital Expenditures -$870.0K -$3.920M
Free Cash Flow $3.540M $5.450M
YoY Change -35.05% -50.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
22755705 shares
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
805000
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6189000
CY2017Q2 us-gaap Assets Current
AssetsCurrent
14899000
CY2017Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11547000
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4314000
CY2017Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
92206000
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5247000
CY2017Q2 us-gaap Assets
Assets
88710000
CY2017Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
593000
CY2017Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
238000
CY2017Q2 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
853000
CY2017Q2 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
33000
CY2017Q2 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
831000
CY2017Q2 us-gaap Capital Leases Future Minimum Payments Remainder Of Fiscal Year
CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear
306000
CY2017Q2 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
0
CY2017Q2 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
0
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
76000
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22755705 shares
CY2017Q2 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
22000
CY2017Q2 us-gaap Capital Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate
CapitalLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRate
0.035 pure
CY2017Q2 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
514000
CY2017Q2 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
0
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22953365 shares
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
2000
CY2017Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
0
CY2017Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
16638000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
4331000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
5235000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
3951000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
4785000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5218000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2773000
CY2017Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
28293000
CY2017Q2 us-gaap Inventory Net
InventoryNet
1962000
CY2017Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
53287000
CY2017Q2 us-gaap Liabilities
Liabilities
40012000
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
88710000
CY2017Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
29018000
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
10994000
CY2017Q2 us-gaap Long Term Debt
LongTermDebt
31379000
CY2017Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
2660000
CY2017Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
3039000
CY2017Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
3039000
CY2017Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
3039000
CY2017Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
1141000
CY2017Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
21121000
CY2017Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
28719000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
938000
CY2017Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1314000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
902000
CY2017Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2494000
CY2017Q2 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
61000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
3626000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1003000
CY2017Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
61000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
181000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
178000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
424000
CY2017Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2017Q2 infu Capital And Operating Leases Future Minimum Payments Due In Three Years
CapitalAndOperatingLeasesFutureMinimumPaymentsDueInThreeYears
935000
CY2017Q2 infu Medical Equipment In Rental Services Accumulated Depreciation
MedicalEquipmentInRentalServicesAccumulatedDepreciation
32468000
CY2017Q2 infu Unamortized Debt Issuance Expense Current
UnamortizedDebtIssuanceExpenseCurrent
28000
CY2017Q2 infu Medical Equipment In Rental Services Gross
MedicalEquipmentInRentalServicesGross
58669000
CY2017Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2017Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1815000
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6129000
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-43510000
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
48698000
CY2017Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
124000
CY2017Q2 infu Medical Equipment Held For Sale Or Rental
MedicalEquipmentHeldForSaleOrRental
1289000
CY2017Q2 infu Capital And Operating Leases Future Minimum Payments Due Thereafter
CapitalAndOperatingLeasesFutureMinimumPaymentsDueThereafter
938000
CY2017Q2 infu Medical Equipment Net
MedicalEquipmentNet
27004000
CY2017Q2 infu Accumulated Depreciation On Pump Equipment
AccumulatedDepreciationOnPumpEquipment
4900000
CY2017Q2 infu Capital And Operating Leases Future Minimum Payments Due
CapitalAndOperatingLeasesFutureMinimumPaymentsDue
4479000
CY2017Q2 infu Unamortized Value Of Debt Issuance Costs Principal In Year Five
UnamortizedValueOfDebtIssuanceCostsPrincipalInYearFive
26000
CY2017Q2 infu Unamortized Value Of Debt Issuance Costs Principal In Year Four
UnamortizedValueOfDebtIssuanceCostsPrincipalInYearFour
28000
CY2017Q2 infu Unamortized Value Of Debt Issuance Costs Principal Remainder Of Fiscal Year
UnamortizedValueOfDebtIssuanceCostsPrincipalRemainderOfFiscalYear
14000
CY2017Q2 infu Unamortized Value Of Debt Issuance Costs Principal In Year Three
UnamortizedValueOfDebtIssuanceCostsPrincipalInYearThree
28000
CY2017Q2 infu Unamortized Value Of Debt Issuance Costs Principal In Year Two
UnamortizedValueOfDebtIssuanceCostsPrincipalInYearTwo
28000
CY2017Q2 infu Capital And Operating Leases Future Minimum Payments Remainder Of Fiscal Year
CapitalAndOperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
730000
CY2017Q2 infu Medical Equipment In Rental Service Net Of Accumulated Depreciation
MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
25715000
CY2017Q2 infu Capital And Operating Leases Future Minimum Payments Due In Two Years
CapitalAndOperatingLeasesFutureMinimumPaymentsDueInTwoYears
1517000
CY2017Q2 infu Capital And Operating Leases Future Minimum Payments Due In Four Years
CapitalAndOperatingLeasesFutureMinimumPaymentsDueInFourYears
178000
CY2017Q2 infu Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
24994000
CY2017Q2 infu Capital And Operating Leases Future Minimum Payments Due In Five Years
CapitalAndOperatingLeasesFutureMinimumPaymentsDueInFiveYears
181000
CY2017Q2 infu Medical Equipment In Rental Services Reserve
MedicalEquipmentInRentalServicesReserve
486000
CY2017Q2 infu Unamortized Debt Issuance Expense Noncurrent
UnamortizedDebtIssuanceExpenseNoncurrent
96000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
818000
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4989000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
20769000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11581000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4118000
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
91829000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5315000
CY2016Q4 us-gaap Assets
Assets
96344000
CY2016Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
2938000
CY2016Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
2573000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3398000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22669675 shares
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q4 infu Unamortized Debt Issuance Expense Current
UnamortizedDebtIssuanceExpenseCurrent
22000
CY2016Q4 infu Medical Equipment In Rental Services Gross
MedicalEquipmentInRentalServicesGross
59034000
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2016Q4 infu Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
22199000
CY2016Q4 infu Medical Equipment In Rental Services Reserve
MedicalEquipmentInRentalServicesReserve
551000
CY2016Q4 infu Unamortized Debt Issuance Expense Noncurrent
UnamortizedDebtIssuanceExpenseNoncurrent
87000
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22867335 shares
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2016Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
2675000
CY2016Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
12436000
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
31239000
CY2016Q4 us-gaap Inventory Net
InventoryNet
2166000
CY2016Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
53438000
CY2016Q4 us-gaap Liabilities
Liabilities
45655000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
96344000
CY2016Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
29216000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16439000
CY2016Q4 us-gaap Long Term Debt
LongTermDebt
31891000
CY2016Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
5314000
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
26577000
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
949000
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2872000
CY2016Q4 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
66000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
225000
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1997000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6115000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41142000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
50689000
CY2016Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
109000
CY2016Q4 infu Medical Equipment Held For Sale Or Rental
MedicalEquipmentHeldForSaleOrRental
1642000
CY2016Q4 infu Medical Equipment Net
MedicalEquipmentNet
29678000
CY2016Q4 infu Accumulated Depreciation On Pump Equipment
AccumulatedDepreciationOnPumpEquipment
3900000
CY2016Q4 infu Medical Equipment In Rental Service Net Of Accumulated Depreciation
MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
28036000
CY2016Q4 infu Medical Equipment In Rental Services Accumulated Depreciation
MedicalEquipmentInRentalServicesAccumulatedDepreciation
30447000
dei Amendment Flag
AmendmentFlag
false
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2798000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3322000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9160000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Depreciation Nonproduction
DepreciationNonproduction
200000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.324 pure
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
dei Document Type
DocumentType
10-Q
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
dei Document Period End Date
DocumentPeriodEndDate
2017-06-30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
dei Entity Registrant Name
EntityRegistrantName
InfuSystem Holdings, Inc
dei Entity Central Index Key
EntityCentralIndexKey
0001337013
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
us-gaap Gross Profit
GrossProfit
20990000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12890000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3825000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1241000
us-gaap Interest Expense
InterestExpense
661000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
730000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1231000
us-gaap Operating Expenses
OperatingExpenses
24051000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-5283000
us-gaap Net Income Loss
NetIncomeLoss
-2584000
us-gaap Operating Income Loss
OperatingIncomeLoss
-3061000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-764000
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
29906000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
500000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-103000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
28000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
28000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1893000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
2623000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
87000
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
19105000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3182000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
24419000
us-gaap Sales Revenue Net
SalesRevenueNet
34596000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
4690000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5181000
dei Trading Symbol
TradingSymbol
INFU
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22710470 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22710470 shares
infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
4446000
infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
3200000
infu Pump Equipments Net
PumpEquipmentsNet
14000000
us-gaap Interest Expense
InterestExpense
632000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-5360000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1834000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-13000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8295000
us-gaap Depreciation Nonproduction
DepreciationNonproduction
300000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.215 pure
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Gross Profit
GrossProfit
23700000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13061000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
247000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
485438 shares
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
53000
infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
4422000
infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
3100000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1869000
us-gaap Operating Expenses
OperatingExpenses
22848000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3478000
us-gaap Net Income Loss
NetIncomeLoss
194000
us-gaap Operating Income Loss
OperatingIncomeLoss
852000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-605000
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
32730000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
500000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
27000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
33000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
7187000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1827000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
126000
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
32575000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2814000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
29190000
us-gaap Sales Revenue Net
SalesRevenueNet
36417000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3687000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5139000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23069900 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22584462 shares
CY2016 infu Pump Equipments Net
PumpEquipmentsNet
13900000
CY2017Q1 infu Leverage Ratio
LeverageRatio
2.96 pure
CY2016Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
922000
CY2016Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4789000
CY2016Q2 us-gaap Depreciation Nonproduction
DepreciationNonproduction
100000
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2016Q2 us-gaap Gross Profit
GrossProfit
11143000
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6392000
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
118000
CY2016Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
489484 shares
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-35000
CY2016Q2 us-gaap Interest Expense
InterestExpense
327000
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
10705000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
153000
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
438000
CY2016Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-320000
CY2016Q2 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
16242000
CY2016Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
300000
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7000
CY2016Q2 infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
1600000
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22620386 shares
CY2016Q2 infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
2191000
CY2016Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1067000
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
18123000
CY2016Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1881000
CY2016Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2324000
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23109870 shares
CY2017Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1387000
CY2017Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4624000
CY2017Q2 us-gaap Depreciation Nonproduction
DepreciationNonproduction
100000
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2017Q2 us-gaap Gross Profit
GrossProfit
10341000
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6425000
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1491000
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-385000
CY2017Q2 us-gaap Interest Expense
InterestExpense
333000
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
11433000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-1106000
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1092000
CY2017Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-399000
CY2017Q2 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
14769000
CY2017Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
300000
CY2017Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-66000
CY2017Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1326000
CY2017Q2 us-gaap Sales Revenue Net
SalesRevenueNet
16942000
CY2017Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2173000
CY2017Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2295000
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22740050 shares
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22740050 shares
CY2017Q2 infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
1977000
CY2017Q2 infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
1600000

Files In Submission

Name View Source Status
0001193125-17-252772-index-headers.html Edgar Link pending
0001193125-17-252772-index.html Edgar Link pending
0001193125-17-252772.txt Edgar Link pending
0001193125-17-252772-xbrl.zip Edgar Link pending
d412717d10q.htm Edgar Link pending
d412717dex311.htm Edgar Link pending
d412717dex312.htm Edgar Link pending
d412717dex321.htm Edgar Link pending
d412717dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g412717g74r28.jpg Edgar Link pending
infu-20170630.xml Edgar Link completed
infu-20170630.xsd Edgar Link pending
infu-20170630_cal.xml Edgar Link unprocessable
infu-20170630_def.xml Edgar Link unprocessable
infu-20170630_lab.xml Edgar Link unprocessable
infu-20170630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending